PolyPid is a clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary Polymer-Lipid Encapsulation matrix (PLEX) technology. Co.'s product candidates are designed to address diseases with unmet medical needs by pairing its PLEX technology with drugs already approved by the U.S. Food and Drug Administration. Co.'s PLEX technology is designed to deliver drugs directly to precise sites in the body at predetermined release rates and over durations ranging from several days to several months. Co.'s primary product candidate, D-PLEX100, is for abdominal (soft) tissue. We show 2 historical shares outstanding datapoints in our PYPD shares outstanding history coverage, used to compute PYPD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PYPD market cap history over the course of time is important for investors
interested in comparing PYPD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PYPD versus a peer is one thing; comparing
PYPD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PYPD can fluctuate over the course of history.
With this page we aim to empower investors researching PYPD by allowing them to research the PYPD market cap history. |
Free PYPD Email Alerts:
Video: The Importance of Market Cap
